BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in Supply Disruption — Jubilant Cadista Pharmaceutica
BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in Supply Disruption — Jubilant Cadista Pharmaceutica is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in; Manufacturer: Jubila
| Drug name | BuPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, packaged in |
|---|---|
| Manufacturer | Jubilant Cadista Pharmaceuticals, Inc. |
| Recall/Disruption reason | Failed Impurities/Degradation Specifications: high out of specification results for one of the known degradation product |
| Risk classification | Low Risk — Unlikely to Cause Adverse Health Effects |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0670-2017 |
| Initiation date | 20160408 |
| Quantity affected | 81,077 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →